Galanin Receptor 1 (GALR1) (C-Term) Peptide
Quick Overview for Galanin Receptor 1 (GALR1) (C-Term) Peptide (ABIN977261)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- CLAYSNSSVN PIIYAFLSEN FRKAYKQVFK CHIRKDSHLS DTKESKSRID
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-GALR1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Galanin Receptor 1 (GALR1)
-
Background
-
The neuropeptide galanin elicits a range of biological effects by interaction with specific G-protein-coupled receptors. Galanin receptors are seven-transmembrane proteins shown to activate a variety of intracellular second-messenger pathways. GALR1 inhibits adenylyl cyclase via a G protein of the Gi/Go family. GALR1 is widely expressed in the brain and spinal cord, as well as in peripheral sites such as the small intestine and heart.
Alias Symbols: GALNR, GALNR1
Protein Interaction Partner: GAL
Protein Size: 349 -
Molecular Weight
- 38 kDa
-
Gene ID
- 2587
-
NCBI Accession
- NM_001480, NP_001471
-
UniProt
- P47211
Target
-